Goldfarb Gross Seligman & Co.

Goldfarb Gross Seligman & Co.‘s broad practice handles a diverse range of matters, including class actions and tender processes. Practice head Hili Cohen maintains a technology focused practice, assisting a range of clients across the medical devices, digital health, and pharma industries with R&D and licensing related transactions, in addition to advising on clinical trials and joint ventures. Ofir Goldstein has exceptional knowledge of technology related licensing agreements, capital financings, and investment agreements on both a domestic and international scale, acting fur numerous start-ups and global life sciences companies. Roy Lieber, Tami Fishman Jutkowitz , Sharon Gazit , and Judy Amidor departed the practice in early 2023.